NephroGenex (NRX) Tops Q3 EPS by 12c

NephroGenex (NASDAQ: NRX) reported Q3 EPS of ($0.53), $0.12 better than the analyst estimate of ($0.65).

For earnings history and earnings-related data on NephroGenex (NRX) click here.

You May Also Be Interested In

• Blackhawk Network (HAWK) Reports Q2 Loss of $0.07; Offers Guidance
• Gemini Space Station, Inc. (GEMI) Misses Q2 EPS by 32c
• KULR Technology Group (KULR) Misses Q2 EPS by 39c